Ensysce Biosciences (ENSC) Misses Q1 EPS by 139c
Tweet
Share
E-mailGet Alerts ENSC Hot Sheet
Join SI Premium – FREE
Ensysce Biosciences (NASDAQ: ENSC) reported Q1 EPS of ($1.39). Revenue for the quarter came in at $1.32 million.
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
- JPMorgan Downgrades Supreme Industries (SI:IN) to Neutral
- Ensysce Biosciences begins final phase of opioid overdose study
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
